Metildrol

Methylprednisolone, the active ingredient in Metildrol, is a corticosteroid presented as an oral tablet for oral use. It provides anti‑inflammatory and immunosuppressive effects for conditions such as rheumatoid arthritis, asthma, and other autoimmune disorders.

GNH USA supplies Metildrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metildrol, a glucocorticoid, is employed to control inflammation and immune‑mediated disease processes.

- Rheumatoid arthritis: reduces joint inflammation, pain, and swelling. - Asthma: diminishes airway inflammation and improves breathing. - Allergic reactions: alleviates severe allergic symptoms and edema. - Dermatologic inflammatory conditions: controls skin inflammation such as eczema or psoriasis flares. - Autoimmune diseases: suppresses abnormal immune activity in conditions like systemic lupus erythematosus.

Adverse reactions may occur with systemic corticosteroid therapy.

Common Side Effects: - Increased appetite and weight gain. - Insomnia or mood changes. - Elevated blood glucose levels. - Gastrointestinal discomfort or dyspepsia. - Fluid retention and mild edema. - Skin thinning or easy bruising.

Serious or Rare Side Effects: - Adrenal insufficiency on abrupt discontinuation. - Severe infections, including opportunistic pathogens. - Osteoporosis with long‑term use. - Cataracts or glaucoma. - Psychosis or severe mood disorders. - Anaphylaxis or severe allergic reaction.

Before initiating therapy, consider the following safety measures.

- Assess infection risk: evaluate for active bacterial, viral, or fungal infections. - Monitor blood glucose: patients with diabetes may need tighter control. - Review bone health: consider calcium and vitamin D supplementation for long‑term use. - Evaluate psychiatric history: corticosteroids can exacerbate mood disorders. - Check vaccination status: avoid live vaccines during treatment. - Store below 25°C: keep in the original pack, protect from moisture and light.

Methylprednisolone can alter the effects of several concomitant medicines.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure. - Live vaccines: heightened risk of severe infection. - Anticoagulants (e.g., warfarin): potential enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may require dose adjustments due to hyperglycemia. - NSAIDs: increased risk of gastrointestinal ulceration or bleeding. - Non‑live vaccines: possible reduced immunogenic response, monitor efficacy.